PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2574975-3	1989	In the present study, it was found that the effects of the DA-acting drugs (apomorphine, LY 171555, SKF 38393, sulpiride, Sch 23390 and gamma-butyrolactone) on PKC activity were prevented by prior diminution of the endogenous stores of DA with alpha-methyl-p-tyrosine (alpha-MT) or reserpine.	Reserpine	282-291	proline rich transmembrane protein 2	Homo sapiens	160-163	
2574975-5	1989	Furthermore, since reserpine decreased the evoked release of DA, these results raise the possibility that PKC may be involved in the vesicular release process.	Reserpine	19-28	proline rich transmembrane protein 2	Homo sapiens	106-109